Kenneth Allen Myszkowski, CFO: Arrowhead Pharmaceuticals ARWR Sell · Filed 23/06/29

Trade details

Type: Insider sale
Amount: $543,000
Shares · price: 15,000 sh · $36.20 a share
Held after: 381,704 sh
Stock: Arrowhead Pharmaceuticals ARWR
Person: Kenneth Allen MyszkowskiCFO
Trade date: 23/06/27
Filed: 23/06/29
Days to filing: 2 days

Sold 3.8% of holdings

Share of holding sold: 3.8%

Arrowhead Pharmaceuticals trades, last 26 weeks

What else happened in Arrowhead Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/05/28~23/07/27

Kenneth Allen Myszkowski's recent trades

Kenneth Allen MyszkowskiCFO
Planned saleArrowhead Pharmaceuticals
Planned sale
Arrowhead Pharmaceuticals
ARWR
$761.7K
40,000 sh
$761.7K
Filed 25/07/10
Traded 25/07/10
Kenneth Allen MyszkowskiCFO
Sell10b5-1 planArrowhead Pharmaceuticals
Sell10b5-1 plan
Arrowhead Pharmaceuticals
ARWR
$349.6K
17,765 sh
$349.6K
Filed 25/01/07
Traded 25/01/06
Kenneth Allen MyszkowskiCFO
Sell10b5-1 planArrowhead Pharmaceuticals
Sell10b5-1 plan
Arrowhead Pharmaceuticals
ARWR
$196.9K
10,000 sh
$196.9K
Filed 25/01/07
Traded 25/01/07
Kenneth Allen MyszkowskiCFO
Sell10b5-1 planArrowhead Pharmaceuticals
Sell10b5-1 plan
Arrowhead Pharmaceuticals
ARWR
$189K
9,402 sh
$189K
Filed 25/01/07
Traded 25/01/06
Kenneth Allen MyszkowskiCFO
Sell10b5-1 planArrowhead Pharmaceuticals
Sell10b5-1 plan
Arrowhead Pharmaceuticals
ARWR
$157.6K
8,000 sh
$157.6K
Filed 25/01/07
Traded 25/01/07